Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
03/28/2013 | WO2013044089A1 Density analysis of organisms by magnetic levitation |
03/28/2013 | WO2013044018A1 Methods and compositions for nucleic acid sequencing |
03/28/2013 | WO2013043936A1 Methods and kits for determining dna repair capacity |
03/28/2013 | WO2013043878A2 Alternative splicing variants of genes associated with prostate cancer risk and survival |
03/28/2013 | WO2013043708A1 Methods and materials for determining source of waste |
03/28/2013 | WO2013043644A1 Methods using liver disease biomarkers |
03/28/2013 | WO2013043628A1 Drug susceptibility using rare cell detection system |
03/28/2013 | WO2013043545A1 Using a field effect device for identifying translocating charge-tagged molecules in a nanopore sequencing device |
03/28/2013 | WO2013043544A1 Translocation and nucleotide reading mechanisms for sequencing nanodevices |
03/28/2013 | WO2013043482A1 Mirna biomarkers for ulcerative colitis |
03/28/2013 | WO2013043132A1 Patient stratification and determining clinical outcome for cancer patients |
03/28/2013 | WO2013043130A1 Method and/or probe for determining glaucoma susceptibility and/or predicting/detecting shallow anterior chamber depth |
03/28/2013 | WO2013043109A2 Device and method for processing a patient sample |
03/28/2013 | WO2013043041A2 Methods and compositions for diagnosing familial hypercholesterolemia |
03/28/2013 | WO2013042993A2 Sprex-dna chip kit for detecting high-resolution mica alleles |
03/28/2013 | WO2013042964A2 Novel bacteriophage and antibacterial composition comprising the same |
03/28/2013 | WO2013042960A2 Method for preparing microvesicular adam15 |
03/28/2013 | WO2013042731A1 Simple method for detecting pluripotent stem cells genetically modified by homologous recombination |
03/28/2013 | WO2013042111A2 Platelet analysis system |
03/28/2013 | WO2013042077A1 Diagnosis of tuberculosis |
03/28/2013 | WO2013041925A1 Methods and compositions for characterizing phenotypes using kinome analysis |
03/28/2013 | WO2013041921A1 Molecular testing of multiple pregnancies |
03/28/2013 | WO2013041913A1 Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage |
03/28/2013 | WO2013041878A1 Analysis of a polymer comprising polymer units |
03/28/2013 | WO2013041853A1 Probe with multiple target region specificity and of tripartite character |
03/28/2013 | WO2013041731A1 Marker gene based diagnosis, staging and prognosis of prostate cancer |
03/28/2013 | WO2013041724A1 Human keratinocytes ptch1 cell line |
03/28/2013 | WO2013041718A1 4-hydroxybutyrate detection |
03/28/2013 | WO2013041692A2 Method to predict the presence of inflammation or itaconic acid, irg1 and/or protein irg1 in a subject and pharmaceutical composition for treating or preventing inflammation |
03/28/2013 | WO2013041684A1 Materials and methods for prognosis of progression of barrett's esophagus |
03/28/2013 | WO2013041577A1 Methods for the diagnosis of amyotrophic lateral sclerosis and frontotemporal lobar degeneration |
03/28/2013 | WO2013041241A1 Ubiquitin chain analysis |
03/28/2013 | WO2013041194A1 Use of g-clamp for improved allele-specific pcr |
03/28/2013 | WO2013041031A1 Gene copy number variation measurement method |
03/28/2013 | WO2013041021A1 Method for analyzing quantification of gene expression |
03/28/2013 | WO2013040992A1 Double-stranded nucleic acid, use and kit thereof in ribonuclease detection |
03/28/2013 | WO2013040840A1 Methods and agents for preventing, diagnosing, treating or predicting general bacterial infection diseases |
03/28/2013 | WO2013040773A1 Method and system for determining chromosome aneuploidy of single cell |
03/28/2013 | WO2013040758A1 Gene related to bladder transitional cell carcinoma susceptibility and prediction method and system thereof |
03/28/2013 | WO2013012749A3 Human zona pellucida glycoproteins, their oligosaccharides, and uses thereof |
03/28/2013 | WO2013009143A9 Marker for diagnosing diabetic retinopathy |
03/28/2013 | WO2013009084A9 Composition for simultaneously detecting mycobacterium tuberculosis and nontuberculous mycobacteria by means of real-time multiplex polymerase chain reaction comprising nested hybridization pna probe system having parallel binding structure, and method for detection using same |
03/28/2013 | WO2013009070A3 Nested hybridization pna probe system having parallel binding structure |
03/28/2013 | WO2013007944A3 Material for supported synthesis and method for growing oligonucleotides or peptides |
03/28/2013 | WO2013006745A3 High throughput genome-wide translocation sequencing |
03/28/2013 | WO2013006312A3 Reagent storage on a droplet actuator |
03/28/2013 | WO2013003585A3 Enrichment of nucleic acids by complimentary capture |
03/28/2013 | WO2013002894A4 Indicator device |
03/28/2013 | WO2013001465A3 Method for classifying the presence or absence of a microorganism in a biological medium |
03/28/2013 | WO2012174187A3 Methods, compositions, and kits for determining human immunodeficiency virus (hiv) |
03/28/2013 | WO2012172221A3 Molecular signature of pigment spots on the skin, associated with extracellular matrix organization |
03/28/2013 | WO2012170936A3 Patterned flow-cells useful for nucleic acid analysis |
03/28/2013 | WO2012167083A3 Method for measuring somatic dna mutational profiles |
03/28/2013 | WO2012166848A3 Methods and compositions for the detection of functional clostridium difficile toxins |
03/28/2013 | WO2012166824A3 Methods and kits that identify tumors responsive to src inhibitors |
03/28/2013 | WO2012162660A3 Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies |
03/28/2013 | WO2012162563A3 Method for exosomal biomarker detection by electric field-induced release and measurement |
03/28/2013 | WO2012160551A3 Methods and compositions for determining heart failure or a risk of heart failure |
03/28/2013 | WO2012159121A9 Microbe detection via hybridizing magnetic relaxation nanosensors |
03/28/2013 | WO2012154979A3 Method of detecting cancer through generalized loss of stability of epigenetic domains, and compositions thereof |
03/28/2013 | WO2012153337A3 Anti-microbial peptides and uses of same |
03/28/2013 | WO2012107596A3 Marker sequences for diagnosing prostate cancer, and use thereof |
03/28/2013 | WO2012037196A8 METHODS OF TREATING AUTOIMMUNE DISEASES WITH ANTI-FCεRI ANTIBODIES |
03/28/2013 | WO2011045349A3 Methods for diagnosing and treating a pathology associated with a synonymous mutation occuring within a gene of interest |
03/28/2013 | US20130079425 Urokinase-Type Plasminogen Activator Protein /Plasminogen Activator Inhibitor Type-1 Protein Selected Reaction Monitoring Assay |
03/28/2013 | US20130079424 Methods for identifying leukemia stem cells and distinguishing them from normal hematopietic stem cells in patients with acute myeloid leukemia: uses in diagnosis, treatment, and research |
03/28/2013 | US20130079423 Diagnostic methods involving loss of heterozygosity |
03/28/2013 | US20130079390 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection |
03/28/2013 | US20130079386 Diagnostics of b-cell lymphoma |
03/28/2013 | US20130079384 Means and Methods for Determining Risk of Cardiovascular Disease |
03/28/2013 | US20130079254 Microfluidic dialysis device |
03/28/2013 | US20130079253 Microarray-based sample analysis system |
03/28/2013 | US20130079246 Methods and Tools for Screening Agents Exhibiting an Activity on Receptors of the Tumor Necrosis Factor Receptor Superfamily |
03/28/2013 | US20130079245 Biomarkers for Ulcerative Colitis and Crohn's Disease |
03/28/2013 | US20130079244 Methods of predicting predisposition to or risk of kidney disease |
03/28/2013 | US20130079241 Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse |
03/28/2013 | US20130079239 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
03/28/2013 | US20130079238 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
03/28/2013 | US20130079236 Systems and methods for multi-analysis |
03/28/2013 | US20130079234 Gene expression profiling of primary breast carcinomas using arrays of candidate genes |
03/28/2013 | US20130079233 Methods and Systems for Predicting HIV-1 Coreceptor Tropism |
03/28/2013 | US20130079232 Methods and compositions for nucleic acid sequencing |
03/28/2013 | US20130079231 Methods for obtaining a sequence |
03/28/2013 | US20130078669 Method And Devices For The Cross-Referencing Of Identification Of Tissue Slice Supports For Microtomised Analytical Samples |
03/28/2013 | US20130078666 Scaffold-based organotypic culture for the long-term cultivation of human epidermal stem cells |
03/28/2013 | US20130078664 Methods for assaying percentage of glycated hemoglobin |
03/28/2013 | US20130078663 Pore-Limit Electrophoresis (PLE) Microchannel Assays |
03/28/2013 | US20130078661 Compounds and Methods for FRET Based Measurement of Enzyme Activity |
03/28/2013 | US20130078660 Methods and compositions for detecting protein modifications |
03/28/2013 | US20130078659 Method for quantitatively determining ldl cholesterols |
03/28/2013 | US20130078656 Artificial immune system: methods of use |
03/28/2013 | US20130078652 Methods and kits for determining von willebrand factor activity in the absence of ristocetin and for determining the activity of adamts-13 protease |
03/28/2013 | US20130078650 Identifying material from a breast duct |
03/28/2013 | US20130078645 Biomarkers |
03/28/2013 | US20130078644 Post-Translational Modifications Identified by Elemental Analysis |
03/28/2013 | US20130078641 Sample processing method and device |
03/28/2013 | US20130078640 Processes for detection of nucleic acids |
03/28/2013 | US20130078639 System and method of detecting and correcting for nucleic acid damage |
03/28/2013 | US20130078638 Bead Emulsion Nucleic Acid Amplification |
03/28/2013 | US20130078637 Antipsychotic-induced parkinsonism genotypes and methods of using same |